EUVIMEDEUVIMED entdecken
Open Access

Involvement of TLR9 in priming the immune response in oral papillomatosis induced by low-risk HPV

Elena Cristina Andrei, Maria Cristina Munteanu, Cristina Jana Busuioc, Cătălina Gabriela Pisoschi, Garofiţa Olivia Mateescu, Sanda Amelia Drăcea, Ileana Monica Baniţă

Romanian Journal of Morphology and Embryology · 2023

DOI: 10.47162/rjme.64.2.08 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Journal of Morphology and Embryology, 2023. Verfasst von Elena Cristina Andrei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biochemistry, Department of Oro-Maxillary Surgery, University of Medicine and Pharmacy of Craiova, Romania; catalina.pis…. Hauptthemen laut MEDLINE: Papillomavirus Infections, Papilloma. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral papillomatosis represents a benign lesion of the oral mucosa often induced by human papillomavirus (HPV) or having a non-infection local or general etiology. HPVs are very well adapted and efficient viruses able to produce changes in the immune system, endowed with the ability to replicate in the keratinocytes and to remain silent. The natural evolution of HPV infection is different, depending on the efficiency of the innate immune system. The purpose of this study was to explore Toll-like receptor 9 (TLR9) immunohistochemical expression in low-risk (LR)-HPV oral infection and its ability to facilitate an efficient immune response by activating the macrophages, which serve as main antigen-presenting cells. Samples of two groups of oral mucosae - LR-HPV-positive and HPV-negative - were processed for immunohistochemistry technique and incubated with antibody against TLR9 and cluster of differentiation 68 (CD68). Image analysis and morphometry were conducted to assess the intensity of TLR9 immune signal in the epithelium and the number of macrophages labeled by CD68. We found a statistically significant difference between macrophage count for the subjects in HPV-positive and HPV-negative groups; thought no significant differences of TLR9 immune signal was noted, which demonstrates a diminished immune response in HPV-positive group, probably influencing the time of lesion's clearance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsPapillomaHumansToll-Like Receptor 9KeratinocytesImmunityPapillomaviridae

Substanzen

Toll-Like Receptor 9TLR9 protein, human

Autor:innen und Institutionen

  • Department of Pharmaceutical Biochemistry, Department of Oro-Maxillary Surgery, University of Medicine and Pharmacy of Craiova, Romania; catalina.pisoschi@umfcv.ro; cristina.munteanu@umfcv.ro.

Zitieren

APA

Andrei, E. C., Munteanu, M. C., Busuioc, C. J., Pisoschi, C. G., Mateescu, G. O., Drăcea, S. A., & Baniţă, I. M. (2023). Involvement of TLR9 in priming the immune response in oral papillomatosis induced by low-risk HPV. Romanian Journal of Morphology and Embryology. https://doi.org/10.47162/rjme.64.2.08

Vancouver

Andrei EC, Munteanu MC, Busuioc CJ, Pisoschi CG, Mateescu GO, Drăcea SA, et al. Involvement of TLR9 in priming the immune response in oral papillomatosis induced by low-risk HPV. Romanian Journal of Morphology and Embryology. 2023. doi:10.47162/rjme.64.2.08

BibTeX
@article{Andrei2023,
  author = {Andrei, Elena Cristina and Munteanu, Maria Cristina and Busuioc, Cristina Jana and Pisoschi, Cătălina Gabriela and Mateescu, Garofiţa Olivia and Drăcea, Sanda Amelia and Baniţă, Ileana Monica},
  title = {Involvement of TLR9 in priming the immune response in oral papillomatosis induced by low-risk HPV},
  journal = {Romanian Journal of Morphology and Embryology},
  year = {2023},
  doi = {10.47162/rjme.64.2.08}
}
Kostenlos starten →